NCT02251145View on ClinicalTrials.gov

Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

June 30, 2002

Conditions
Healthy
Interventions
DRUG

Tipranavir low dose

DRUG

Tipranavir high dose

DRUG

Ritonavir low dose

DRUG

Ritonavir high dose

DRUG

Tenofovir disoproxil fumarate

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02251145 - Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers | Biotech Hunter | Biotech Hunter